These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 39085855)

  • 21. Diabetes severity, metabolic syndrome, and the risk of erectile dysfunction.
    Weinberg AE; Eisenberg M; Patel CJ; Chertow GM; Leppert JT
    J Sex Med; 2013 Dec; 10(12):3102-9. PubMed ID: 24010555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of METS-IR index with prevalence of erectile dysfunction in US adults: a cross-sectional study.
    Sun C; Gao Y; Liang Z; Liu C; Chen M
    Int Urol Nephrol; 2024 Jul; 56(7):2157-2164. PubMed ID: 38403823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pathologic relevance of metabolic criteria in patients with biopsy-proven nonalcoholic fatty liver disease and metabolic dysfunction associated fatty liver disease: A multicenter cross-sectional study in China.
    Yang RX; Zou ZS; Zhong BH; Deng H; He FP; Shi JP; Zhao CY; Mi YQ; Zhou YJ; Di FS; Zheng RD; Du Q; Shang J; Popovic B; Chen J; Fan JG
    Hepatobiliary Pancreat Dis Int; 2021 Oct; 20(5):426-432. PubMed ID: 34246549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction and Validation of Metabolic Dysfunction-Associated Fatty Liver Disease Using Insulin Resistance-Related Indices in the Japanese Population.
    Moriyama K; Inoue N; Imai J; Masuda Y; Yamada C; Kishimoto N; Takashimizu S; Kubo A; Nishizaki Y
    Metab Syndr Relat Disord; 2023 Nov; 21(9):489-496. PubMed ID: 37878804
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of triglyceride-glucose index and HOMA-IR for predicting prevalence and incidence of metabolic syndrome.
    Son DH; Lee HS; Lee YJ; Lee JH; Han JH
    Nutr Metab Cardiovasc Dis; 2022 Mar; 32(3):596-604. PubMed ID: 35090800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin Resistance/Sensitivity Measures as Screening Indicators of Metabolic-Associated Fatty Liver Disease and Liver Fibrosis.
    Khamseh ME; Malek M; Jahangiri S; Nobarani S; Hekmatdoost A; Salavatizadeh M; Soltanieh S; Chehrehgosha H; Taheri H; Montazeri Z; Attaran F; Ismail-Beigi F; Alaei-Shahmiri F
    Dig Dis Sci; 2024 Apr; 69(4):1430-1443. PubMed ID: 38438774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can Visceral Adiposity Index Serve as a Simple Tool for Identifying Individuals with Insulin Resistance in Daily Clinical Practice?
    Štěpánek L; Horáková D; Cibičková Ľ; Vaverková H; Karásek D; Nakládalová M; Zapletalová J
    Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31470593
    [No Abstract]   [Full Text] [Related]  

  • 28. The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults.
    Lee JH; Park K; Lee HS; Park HK; Han JH; Ahn SB
    Clin Mol Hepatol; 2022 Oct; 28(4):814-826. PubMed ID: 35680169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Independent and joint association of physical activity and adequate weekday sleep duration with metabolic dysfunction-associated steatotic liver disease.
    Li Y; Guo Y; Tan S
    Clin Res Hepatol Gastroenterol; 2024 Apr; 48(4):102320. PubMed ID: 38484840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated AIP is associated with the prevalence of MAFLD in the US adults: evidence from NHANES 2017-2018.
    Chen Y; Lu C; Ju H; Zhou Q; Zhao X
    Front Endocrinol (Lausanne); 2024; 15():1405828. PubMed ID: 38808115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in insulin resistance mediate the associations between phthalate exposure and metabolic syndrome.
    Ko NY; Lo YC; Huang PC; Huang YC; Chang JL; Huang HB
    Environ Res; 2019 Aug; 175():434-441. PubMed ID: 31158561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The association of triglyceride-glucose-waist circumference with metabolic associated fatty liver disease and the severity of liver steatosis and fibrosis in American adults: a population-based study.
    Wu Z; Huang K; Bao S; Zhang X; Li J; Kong W; Shi Y; Xie Y
    Scand J Gastroenterol; 2024 May; 59(5):561-569. PubMed ID: 38235548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between a metabolic score for insulin resistance and hypertension: results from National Health and Nutrition Examination Survey 2007-2016 analyses.
    Zeng J; Zhang T; Yang Y; Wang J; Zheng D; Hou Y; Tong Y; Fan X; Wang X; Fang Y
    Front Endocrinol (Lausanne); 2024; 15():1369600. PubMed ID: 38711979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin resistance determines a differential response to changes in dietary fat modification on metabolic syndrome risk factors: the LIPGENE study.
    Yubero-Serrano EM; Delgado-Lista J; Tierney AC; Perez-Martinez P; Garcia-Rios A; Alcala-Diaz JF; Castaño JP; Tinahones FJ; Drevon CA; Defoort C; Blaak EE; Dembinska-Kieć A; Risérus U; Lovegrove JA; Perez-Jimenez F; Roche HM; Lopez-Miranda J
    Am J Clin Nutr; 2015 Dec; 102(6):1509-17. PubMed ID: 26561628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential screening indicators for early diagnosis of NAFLD/MAFLD and liver fibrosis: Triglyceride glucose index-related parameters.
    Xue Y; Xu J; Li M; Gao Y
    Front Endocrinol (Lausanne); 2022; 13():951689. PubMed ID: 36120429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between complement C3 and the prevalence of metabolic-associated fatty liver disease in a Chinese population: a cross-sectional study.
    Feng L; Zhao Y; Wang WL
    BMJ Open; 2021 Oct; 11(10):e051218. PubMed ID: 34711595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum antioxidant status is associated with metabolic syndrome among U.S. adults in recent national surveys.
    Beydoun MA; Shroff MR; Chen X; Beydoun HA; Wang Y; Zonderman AB
    J Nutr; 2011 May; 141(5):903-13. PubMed ID: 21451127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum antioxidant concentrations and metabolic syndrome are associated among U.S. adolescents in recent national surveys.
    Beydoun MA; Canas JA; Beydoun HA; Chen X; Shroff MR; Zonderman AB
    J Nutr; 2012 Sep; 142(9):1693-704. PubMed ID: 22810988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IS HOMEOSTASIS MODEL ASSESSMENT FOR INSULIN RESISTANCE >2.5 A DISTINGUISHED CRITERIA FOR METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE IDENTIFICATION?
    Barreto BFM; Punaro GR; Elias MC; Parise ER
    Arq Gastroenterol; 2022; 59(3):402-407. PubMed ID: 36102439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Associations Between the Triglyceride to High-Density Lipoprotein Cholesterol Ratio and Metabolic Syndrome, Insulin Resistance, and Lifestyle Habits in Healthy Japanese.
    Moriyama K
    Metab Syndr Relat Disord; 2020 Jun; 18(5):260-266. PubMed ID: 32191558
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.